CLINICAL_TRIALS
trial_result
· 2023-08-25
Clinical Trial Update: Safety Study of a Helper Peptide Vaccine Plus Pembrolizumab [Phase 1, Phase 2]
Summary
A safety study of a helper peptide vaccine in combination with pembrolizumab in melanoma has completed phases 1 and 2 with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Craig L Slingluff, Jr | Conditions: Melanoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-08-25